Search

Your search keyword '"Schulz-Key H"' showing total 92 results

Search Constraints

Start Over You searched for: Author "Schulz-Key H" Remove constraint Author: "Schulz-Key H" Database MEDLINE Remove constraint Database: MEDLINE
92 results on '"Schulz-Key H"'

Search Results

1. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.

2. Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.

Catalog

Books, media, physical & digital resources

3. Chemokines and cytokines in patients with an occult Onchocerca volvulus infection.

4. Applied field research for comprehensive helminth infection control.

5. Of mice, cattle, and humans: the immunology and treatment of river blindness.

6. Microfilariae of the filarial nematode Litomosoides sigmodontis exacerbate the course of lipopolysaccharide-induced sepsis in mice.

7. Antibody and cytokine responses in Dracunculus medinensis patients at distinct states of infection.

8. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.

9. Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.

10. Cytokine and chemokine responses in patients co-infected with Entamoeba histolytica/dispar, Necator americanus and Mansonella perstans and changes after anti-parasite treatment.

11. Chemokines in onchocerciasis patients after a single dose of ivermectin.

12. Longitudinal clinical and serological survey of abdominal angiostrongyliasis in Guaporé, southern Brazil, from 1995 to 1999.

13. Long-term observations on mouse strains experimentally infected with Angiostrongylus costaricensis.

14. Parasite-specific antibody and cytokine profiles in newborns from Plasmodium falciparum and Entamoeba histolytica/dispar-infected mothers.

15. The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis.

16. Impact of parental onchocerciasis and intensity of transmission on development and persistence of Onchocerca volvulus infection in offspring: an 18 year follow-up study.

17. Angiostrongylus costaricensis infection in C57BL/6 mice: MHC-II deficiency results in increased larval elimination but unaltered mortality.

18. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.

19. Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis.

20. Pro-inflammatory (IL-1beta, IL-18) cytokines and IL-8 chemokine release by PBMC in response to Echinococcus multilocularis metacestode vesicles.

21. Litomosoides sigmodontis cystatin acts as an immunomodulator during experimental filariasis.

22. Cellular immune responses and cytokine production in BALB/c and C57BL/6 mice during the acute phase of Angiostrongylus costaricensis infection.

23. Parasite-specific antibody and cellular immune responses in human infected with Necator americanus and Oesophagostomum bifurcum.

24. A stochastic model for the aggregation of Onchocerca volvulus in nodules.

25. Determinants for resistance and susceptibility to microfilaraemia in Litomosoides sigmodontis filariasis.

26. Detection of the acute phase of abdominal angiostrongyliasis with a parasite-specific IgG enzyme linked immunosorbent assay.

27. Litomosoides sigmodontis in mice: reappraisal of an old model for filarial research.

28. The role of nitric oxide in the innate resistance to microfilariae of Litomosoides sigmodontis in mice.

29. Prenatal immune priming with helminth infections: parasite-specific cellular reactivity and Th1 and Th2 cytokine responses in neonates.

30. Litomosoides sigmodontis: dynamics of the survival of microfilariae in resistant and susceptible strains of mice.

31. Isolation of Angiostrongylus costaricensis first-stage larvae from rodent feces on a Percoll gradient.

32. Cytokine and chemokine secretion by human peripheral blood cells in response to viable Echinococcus multilocularis metacestode vesicles.

33. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.

34. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.

35. Experimental Angiostrongylus costaricensis infection in mice: immunoglobulin isotype responses and parasite-specific antigen recognition after primary low-dose infection.

36. Use of P-glycoprotein gene probes to investigate anthelmintic resistance in Haemonchus contortus and comparison with Onchocerca volvulus.

37. Antigenicity and specificity of very low molecular weight Onchocerca volvulus polypeptides in the range 2.2-12.5 kD.

38. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

39. Filariidae: cross-protection in filarial infections.

40. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.

41. Onchocerca volvulus provides ligands for the stimulation of human gamma/delta T lymphocytes expressing V delta 1 chains.

42. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.

43. Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients.

44. Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.

45. Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov33).

46. Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulus.

48. [Ivermectin in the treatment of onchocerciasis: feasibility, compliance and efficacy of a mass treatment].

49. The chemotherapy of onchocerciasis. XIV. Studies with mebendazole citrate.

50. Distribution of microfilariae of Onchocerca lienalis and Onchocerca gutturosa in the skin of cattle in Germany and their development in Simulium ornatum and Culicoides nubeculosus following artificial infestation.